Xbrane Biopharma
Xbrane Biopharma: Interview with CEO Martin Åmark (Redeye)

2024-11-21 07:25
Redeye recieves an update from Xbrane Biopharma's CEO, Martin Åmark, following the company's newly announced partnership for its Opdivo biosimilar. Among other things we discuss the deal structure, cash runway and ongoing outlicensing of XB003.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Xbrane Biopharma - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -